4
Changes in Ownership
Denali Therapeutics Inc. Filed Acc 0001209191-20-037764
Director sold 400,000 shares at $26.10 ($10,440,000)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Tessier-Lavigne Marc Director | 2020-06-16 | Sale | −400,000 | $26.10 | $10,440,000 | 2,739,043 | D |
| Open-market sales · 400,000 sh · avg $26.10 · $10,440,000 | |||||||
Loading xslF345X03/doc4.xml…